84/100B44.305
USD
0.16
(0.36%)
Market Open
Last updated: · Delayed 15 min
Fair value62.64Plus-29%47Price 44.3178
Q4 FY2026 · Earnings report
EPS estimate 0.78Revenue estimate 5.18B
Q4 FY2026 · Earnings report
EPS estimate 0.78Revenue estimate 5.18B
Boston Scientific price to sales (P/S) ratioWhat is the P/S ratio? The price-to-sales ratio compares a company's market value with its revenue over the last year: what you pay for each dollar of sales.
Boston Scientific's P/S ratio is 3.05: its market cap of 64.22B USD over revenue of 21.07B USD in the last twelve months.
- Today
- 3.05
- Average, 5 years
- 5.25
- Low, 5 years
- 2.94
- High, 5 years
- 6.15
P/S ratio = market cap ÷ revenue (last 12 months) = 64.22B ÷ 21.07B = 3.05
Each day's market cap over the revenue of the last four quarters reported by that day.
P/S ratio by year and by quarter
| Fiscal year | Period ending | P/S ratio | Market cap | Revenue |
|---|---|---|---|---|
| Today | 3.05 | 64.22B | 21.07B | |
| FY2025 | 31 Dec 2025 | 7.03 | 141.16B | 20.07B |
| FY2024 | 31 Dec 2024 | 7.85 | 131.43B | 16.75B |
| FY2023 | 31 Dec 2023 | 5.90 | 84.00B | 14.24B |
| FY2022 | 31 Dec 2022 | 5.22 | 66.19B | 12.68B |
| FY2021 | 31 Dec 2021 | 5.08 | 60.42B | 11.89B |
| FY2020 | 31 Dec 2020 | 5.14 | 50.93B | 9.91B |
| FY2019 | 31 Dec 2019 | 5.86 | 62.92B | 10.74B |
| FY2018 | 31 Dec 2018 | 4.97 | 48.80B | 9.82B |
| FY2017 | 31 Dec 2017 | 3.75 | 33.96B | 9.05B |
| FY2016 | 31 Dec 2016 | 3.50 | 29.36B | 8.39B |
| FY2015 | 31 Dec 2015 | 3.27 | 24.48B | 7.48B |
| FY2014 | 31 Dec 2014 | 2.38 | 17.55B | 7.38B |
| FY2013 | 31 Dec 2013 | 2.26 | 16.12B | 7.14B |
| FY2012 | 31 Dec 2012 | 1.11 | 8.06B | 7.25B |
| FY2011 | 31 Dec 2011 | 1.06 | 8.06B | 7.62B |
| FY2010 | 31 Dec 2010 | 1.47 | 11.49B | 7.81B |
| FY2009 | 31 Dec 2009 | 1.66 | 13.57B | 8.19B |
| FY2008 | 31 Dec 2008 | 1.44 | 11.60B | 8.05B |
| FY2007 | 31 Dec 2007 | 2.07 | 17.29B | 8.36B |
| FY2006 | 31 Dec 2006 | 2.80 | 21.88B | 7.82B |
| FY2005 | 31 Dec 2005 | 3.22 | 20.24B | 6.28B |
| FY2004 | 31 Dec 2004 | 5.29 | 29.73B | 5.62B |
| FY2003 | 31 Dec 2003 | 8.76 | 30.44B | 3.48B |
| FY2002 | 31 Dec 2002 | 5.91 | 17.24B | 2.92B |
| FY2001 | 31 Dec 2001 | 3.75 | 10.02B | 2.67B |
| FY2000 | 31 Dec 2000 | 2.08 | 5.55B | 2.66B |
| FY1999 | 31 Dec 1999 | 3.10 | 8.82B | 2.84B |
| FY1998 | 31 Dec 1998 | 4.66 | 10.41B | 2.23B |
| FY1997 | 31 Dec 1997 | 4.77 | 8.93B | 1.87B |
| FY1996 | 31 Dec 1996 | 7.97 | 11.66B | 1.46B |
| FY1995 | 31 Dec 1995 | 8.19 | 9.06B | 1.11B |
| FY1994 | 31 Dec 1994 | 4.07 | 1.83B | 448.90M |
| FY1993 | 31 Dec 1993 | 3.25 | 1.24B | 380.10M |
| FY1992 | 31 Dec 1992 | 6.46 | 2.04B | 315.20M |
| FY1991 | 31 Dec 1991 | 7.07 | 1.63B | 230.00M |
| Quarter | Period ending | P/S ratio | Market cap | Revenue |
|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 3.00 | 63.24B | 21.07B |
| Q2 FY2026 | 30 Jun 2026 | 3.00 | 63.06B | 21.00B |
| Q1 FY2026 | 31 Mar 2026 | 4.52 | 93.18B | 20.62B |
| Q4 FY2025 | 31 Dec 2025 | 7.04 | 141.38B | 20.08B |
| Q3 FY2025 | 30 Sept 2025 | 7.48 | 144.66B | 19.35B |
| Q2 FY2025 | 30 Jun 2025 | 8.59 | 158.81B | 18.49B |
| Q1 FY2025 | 31 Mar 2025 | 8.49 | 149.02B | 17.55B |
| Q4 FY2024 | 31 Dec 2024 | 7.86 | 131.68B | 16.75B |
| Q3 FY2024 | 30 Sept 2024 | 7.76 | 123.41B | 15.91B |
| Q2 FY2024 | 30 Jun 2024 | 7.38 | 112.37B | 15.23B |
| Q1 FY2024 | 31 Mar 2024 | 6.80 | 100.00B | 14.71B |
| Q4 FY2023 | 31 Dec 2023 | 5.95 | 84.71B | 14.24B |
| Q3 FY2023 | 30 Sept 2023 | 5.62 | 77.33B | 13.76B |
| Q2 FY2023 | 30 Jun 2023 | 5.84 | 78.22B | 13.40B |
| Q1 FY2023 | 31 Mar 2023 | 5.51 | 71.83B | 13.05B |
| Q4 FY2022 | 31 Dec 2022 | 5.23 | 66.29B | 12.68B |
| Q3 FY2022 | 30 Sept 2022 | 4.41 | 55.45B | 12.57B |
| Q2 FY2022 | 30 Jun 2022 | 4.32 | 53.28B | 12.33B |
| Q1 FY2022 | 31 Mar 2022 | 5.20 | 63.24B | 12.16B |
| Q4 FY2021 | 31 Dec 2021 | 5.09 | 60.54B | 11.89B |
| Q3 FY2021 | 30 Sept 2021 | 5.39 | 61.78B | 11.47B |
| Q2 FY2021 | 30 Jun 2021 | 5.43 | 60.77B | 11.20B |
| Q1 FY2021 | 31 Mar 2021 | 5.42 | 54.83B | 10.12B |
| Q4 FY2020 | 31 Dec 2020 | 5.18 | 51.33B | 9.91B |
| Q3 FY2020 | 30 Sept 2020 | 5.32 | 53.81B | 10.11B |
| Q2 FY2020 | 30 Jun 2020 | 4.78 | 48.52B | 10.16B |
| Q1 FY2020 | 31 Mar 2020 | 4.23 | 45.60B | 10.79B |
| Q4 FY2019 | 31 Dec 2019 | 5.87 | 63.05B | 10.74B |
| Q3 FY2019 | 30 Sept 2019 | 5.45 | 56.69B | 10.39B |
| Q2 FY2019 | 30 Jun 2019 | 5.92 | 59.67B | 10.08B |
| Q1 FY2019 | 31 Mar 2019 | 5.40 | 53.65B | 9.94B |
| Q4 FY2018 | 31 Dec 2018 | 4.98 | 48.92B | 9.82B |
| Q3 FY2018 | 30 Sept 2018 | 5.57 | 53.90B | 9.67B |
| Q2 FY2018 | 30 Jun 2018 | 4.75 | 45.14B | 9.50B |
| Q1 FY2018 | 31 Mar 2018 | 4.06 | 37.61B | 9.27B |
| Q4 FY2017 | 31 Dec 2017 | 3.76 | 34.04B | 9.05B |
| Q3 FY2017 | 30 Sept 2017 | 4.53 | 40.02B | 8.83B |
| Q2 FY2017 | 30 Jun 2017 | 4.36 | 37.97B | 8.71B |
| Q1 FY2017 | 31 Mar 2017 | 3.96 | 33.96B | 8.58B |
| Q4 FY2016 | 31 Dec 2016 | 3.51 | 29.46B | 8.39B |
| Q3 FY2016 | 30 Sept 2016 | 3.96 | 32.38B | 8.17B |
| Q2 FY2016 | 30 Jun 2016 | 3.99 | 31.72B | 7.96B |
| Q1 FY2016 | 31 Mar 2016 | 3.31 | 25.40B | 7.67B |
| Q4 FY2015 | 31 Dec 2015 | 3.19 | 23.87B | 7.48B |
| Q3 FY2015 | 30 Sept 2015 | 2.93 | 21.66B | 7.39B |
| Q2 FY2015 | 30 Jun 2015 | 3.23 | 23.74B | 7.34B |
| Q1 FY2015 | 31 Mar 2015 | 3.21 | 23.67B | 7.37B |
| Q4 FY2014 | 31 Dec 2014 | 2.38 | 17.58B | 7.38B |
| Q3 FY2014 | 30 Sept 2014 | 2.14 | 15.65B | 7.33B |
| Q2 FY2014 | 30 Jun 2014 | 2.34 | 16.90B | 7.22B |
| Q1 FY2014 | 31 Mar 2014 | 2.50 | 17.87B | 7.16B |
| Q4 FY2013 | 31 Dec 2013 | 2.24 | 15.98B | 7.14B |
| Q3 FY2013 | 30 Sept 2013 | 2.21 | 15.74B | 7.13B |
| Q2 FY2013 | 30 Jun 2013 | 1.77 | 12.59B | 7.13B |
| Q1 FY2013 | 31 Mar 2013 | 1.48 | 10.54B | 7.15B |
| Q4 FY2012 | 31 Dec 2012 | 1.08 | 7.83B | 7.25B |
| Q3 FY2012 | 30 Sept 2012 | 1.08 | 7.87B | 7.28B |
| Q2 FY2012 | 30 Jun 2012 | 1.09 | 8.07B | 7.42B |
| Q1 FY2012 | 31 Mar 2012 | 1.14 | 8.64B | 7.56B |
| Q4 FY2011 | 31 Dec 2011 | 1.01 | 7.72B | 7.62B |
| Q3 FY2011 | 30 Sept 2011 | 1.15 | 8.95B | 7.78B |
| Q2 FY2011 | 30 Jun 2011 | 1.35 | 10.56B | 7.82B |
| Q1 FY2011 | 31 Mar 2011 | 1.41 | 10.98B | 7.77B |
| Q4 FY2010 | 31 Dec 2010 | 1.48 | 11.56B | 7.81B |
| Q3 FY2010 | 30 Sept 2010 | 1.18 | 9.32B | 7.88B |
| Q2 FY2010 | 30 Jun 2010 | 1.10 | 8.80B | 7.99B |
| Q1 FY2010 | 31 Mar 2010 | 1.34 | 10.93B | 8.14B |
| Q4 FY2009 | 31 Dec 2009 | 1.66 | 13.60B | 8.19B |
| Q3 FY2009 | 30 Sept 2009 | 1.97 | 15.98B | 8.11B |
| Q2 FY2009 | 30 Jun 2009 | 1.89 | 15.28B | 8.06B |
| Q1 FY2009 | 31 Mar 2009 | 1.49 | 11.96B | 8.01B |
| Q4 FY2008 | 31 Dec 2008 | 1.44 | 11.62B | 8.05B |
| Q3 FY2008 | 30 Sept 2008 | 2.25 | 18.42B | 8.20B |
| Q2 FY2008 | 30 Jun 2008 | 2.23 | 18.41B | 8.27B |
| Q1 FY2008 | 31 Mar 2008 | 2.31 | 19.23B | 8.32B |
| Q4 FY2007 | 31 Dec 2007 | 2.08 | 17.38B | 8.36B |
| Q3 FY2007 | 30 Sept 2007 | 2.54 | 21.04B | 8.27B |
| Q2 FY2007 | 30 Jun 2007 | 2.76 | 22.79B | 8.25B |
| Q1 FY2007 | 31 Mar 2007 | 2.63 | 21.81B | 8.29B |
| Q4 FY2006 | 31 Dec 2006 | 3.23 | 25.26B | 7.82B |
| Q3 FY2006 | 30 Sept 2006 | 3.08 | 22.48B | 7.30B |
| Q2 FY2006 | 30 Jun 2006 | 3.30 | 22.36B | 6.78B |
| Q1 FY2006 | 31 Mar 2006 | 3.04 | 19.13B | 6.29B |
| Q4 FY2005 | 31 Dec 2005 | 3.24 | 20.33B | 6.28B |
| Q3 FY2005 | 30 Sept 2005 | 3.00 | 19.05B | 6.34B |
| Q2 FY2005 | 30 Jun 2005 | 3.51 | 22.14B | 6.31B |
| Q1 FY2005 | 31 Mar 2005 | 3.96 | 24.39B | 6.16B |
| Q4 FY2004 | 31 Dec 2004 | 5.26 | 29.60B | 5.62B |
| Q3 FY2004 | 30 Sept 2004 | 6.66 | 33.07B | 4.96B |
| Q2 FY2004 | 30 Jun 2004 | 8.31 | 36.21B | 4.36B |
| Q1 FY2004 | 31 Mar 2004 | 9.53 | 35.75B | 3.75B |
| Q4 FY2003 | 31 Dec 2003 | 8.92 | 31.01B | 3.48B |
| Q3 FY2003 | 30 Sept 2003 | 7.87 | 26.37B | 3.35B |
| Q2 FY2003 | 30 Jun 2003 | 7.78 | 24.88B | 3.20B |
| Q1 FY2003 | 31 Mar 2003 | 5.40 | 16.47B | 3.05B |
| Q4 FY2002 | 31 Dec 2002 | 5.89 | 17.19B | 2.92B |
| Q3 FY2002 | 30 Sept 2002 | 4.57 | 12.70B | 2.78B |
| Q2 FY2002 | 30 Jun 2002 | 4.38 | 11.97B | 2.73B |
| Q1 FY2002 | 31 Mar 2002 | 3.77 | 10.16B | 2.69B |
| Q4 FY2001 | 31 Dec 2001 | 3.70 | 9.89B | 2.67B |
| Q3 FY2001 | 30 Sept 2001 | 3.23 | 8.51B | 2.63B |
| Q2 FY2001 | 30 Jun 2001 | 2.60 | 6.80B | 2.62B |
| Q1 FY2001 | 31 Mar 2001 | 3.82 | 10.09B | 2.64B |
| Q4 FY2000 | 31 Dec 2000 | 2.57 | 6.84B | 2.66B |
| Q3 FY2000 | 30 Sept 2000 | 2.43 | 6.65B | 2.74B |
| Q2 FY2000 | 30 Jun 2000 | 3.21 | 8.92B | 2.78B |
| Q1 FY2000 | 31 Mar 2000 | 3.09 | 8.69B | 2.81B |
| Q4 FY1999 | 31 Dec 1999 | 3.14 | 8.92B | 2.84B |
| Q3 FY1999 | 30 Sept 1999 | 3.73 | 10.47B | 2.81B |
| Q2 FY1999 | 30 Jun 1999 | 6.49 | 17.47B | 2.69B |
| Q1 FY1999 | 31 Mar 1999 | 6.57 | 16.25B | 2.47B |
| Q4 FY1998 | 31 Dec 1998 | 4.74 | 10.58B | 2.23B |
| Q3 FY1998 | 30 Sept 1998 | 4.92 | 10.06B | 2.04B |
| Q2 FY1998 | 30 Jun 1998 | 6.17 | 12.00B | 1.94B |
| Q1 FY1998 | 31 Mar 1998 | 7.06 | 13.50B | 1.91B |
| Q4 FY1997 | 31 Dec 1997 | 4.90 | 9.03B | 1.84B |
| Q3 FY1997 | 30 Sept 1997 | 6.31 | 11.09B | 1.76B |
| Q2 FY1997 | 30 Jun 1997 | 7.13 | 11.80B | 1.66B |
| Q1 FY1997 | 31 Mar 1997 | 7.56 | 11.64B | 1.54B |
| Q4 FY1996 | 31 Dec 1996 | 7.69 | 11.25B | 1.46B |
| Q3 FY1996 | 30 Sept 1996 | 7.66 | 11.37B | 1.48B |
| Q2 FY1996 | 30 Jun 1996 | 5.74 | 7.71B | 1.34B |
| Q1 FY1996 | 31 Mar 1996 | 6.79 | 8.24B | 1.21B |
| Q4 FY1995 | 31 Dec 1995 | 7.71 | 8.53B | 1.11B |
| Q3 FY1995 | 30 Sept 1995 | 8.01 | 6.39B | 797.40M |
| Q2 FY1995 | 30 Jun 1995 | 7.21 | 4.88B | 676.80M |
| Q1 FY1995 | 31 Mar 1995 | 6.56 | 3.67B | 559.40M |
| Q4 FY1994 | 31 Dec 1994 | 5.77 | 2.59B | 449.00M |
| Q3 FY1994 | 30 Sept 1994 | 3.67 | 1.57B | 428.50M |
| Q2 FY1994 | 30 Jun 1994 | 2.88 | 1.19B | 411.90M |
| Q1 FY1994 | 31 Mar 1994 | 3.41 | 1.35B | 396.40M |
| Q4 FY1993 | 31 Dec 1993 | 3.25 | 1.24B | 380.00M |
| Q3 FY1993 | 30 Sept 1993 | 2.71 | 985.14M | 363.30M |
| Q2 FY1993 | 30 Jun 1993 | 3.74 | 1.31B | 349.60M |
| Q1 FY1993 | 31 Mar 1993 | 4.62 | 1.53B | 331.50M |
| Q4 FY1992 | 31 Dec 1992 | 6.33 | 2.00B | 315.20M |
| Q3 FY1992 | 30 Sept 1992 | 5.72 | 1.69B | 294.60M |
| Q2 FY1992 | 30 Jun 1992 | 5.97 | 1.63B | 272.60M |
| Q1 FY1992 | 31 Mar 1992 | 6.06 | 1.53B | 252.20M |
| Q4 FY1991 | 31 Dec 1991 | 6.65 | 1.53B | 230.10M |
| Q3 FY1991 | 30 Sept 1991 | — | 1.56B | — |
| Q2 FY1991 | 30 Jun 1991 | — | 1.54B | — |
| Q1 FY1991 | 31 Mar 1991 | — | 1.63B | — |
Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.
See also:P/E ratio,Market cap,ROE (return on equity),Debt to equity,Current ratio,All ratios
Common questions about Boston Scientific's P/S ratio
Source: Financial Modeling Prep